Phenotypic Suppression of ALS/FTD-Associated Neurodegeneration Highlights Mechanisms of Dysfunction

Journal of Neuroscience - United States
doi 10.1523/jneurosci.1159-19.2019
Full Text
Abstract

Available in full text

Categories
Neuroscience
Date
Authors
Publisher

Society for Neuroscience

Related search

Publisher Correction: L3MBTL1 Regulates ALS/FTD-associated Proteotoxicity and Quality Control

Nature Neuroscience
Neuroscience
2019English

Pathogenic Determinants and Mechanisms of ALS/FTD Linked to Hexanucleotide Repeat Expansions in the C9orf72 Gene

Neuroscience Letters
Neuroscience
2017English

Genetic Screening in Sporadic ALS and FTD

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
2017English

Learning From History-Ftd, ALS and Behaviour

Clinical Neurology
Neurology
2010English

Clinical and Neuropathological Features of ALS/FTD With TIA1 Mutations

Acta neuropathologica communications
Forensic MedicineMolecular NeurosciencePathologyNeurologyCellular
2017English

Pathogenic Mechanisms of Neurodegeneration Based on the Phenotypic Expression of Progressive Forms of Immune-Mediated Neurologic Disease

Degenerative Neurological and Neuromuscular Disease
2012English

Mechanisms of Tau-Induced Neurodegeneration

Acta Neuropathologica
Forensic MedicineMolecular NeurosciencePathologyNeurologyCellular
2009English

Gene Suppression Approaches to Neurodegeneration

Alzheimer's Research and Therapy
NeurologyCognitive Neuroscience
2017English

Modifiers of C9orf72 Dipeptide Repeat Toxicity Connect Nucleocytoplasmic Transport Defects to FTD/ALS

Nature Neuroscience
Neuroscience
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy